Review worldwide bioscience venture capital investment activity and trends for the first six months of 2009. Presented with analysis and charts that detail the private bioscience company arena, covering biopharma therapeutics, diagnostics, devices and biofuels.
Data is presented with recent quarter-over-quarter and half-versus-half periods and is sorted by aggregate dollars raised by financing round, sector, U.S. region and state, including number of financings per round, sector, region, state, and indication & technology areas.
Included is the first-half listing of private bioscience company financings and a comparison of private bioscience venture investment activity versus the public markets of the NBI and the broader DJI Average.
CONTACT US TO REQUEST AN ANNUAL SUBSCRIPTION AND RECEIVE FOUR QUARTERLY UPDATES FOR A FLAT FEE OF $895. Contact Sandra.Baker@cancom.com or call: 215-944-9836
Statistical information and analysis for this report is provided by OnBioVC (OnBioVC.com).